Work

OA23.02 Efficacy and Safety of Necitumumab Continuation Monotherapy in Patients with EGFR-Expressing Tumors in SQUIRE, a Phase 3 Study

Year: 2017

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2016.11.361

Authors: Tudor Ciuleanu, Mark Socinski, Coleman Obasaju, Alexander Luft, Aleksandra Szczęsna, Rodryg Ramlau, Beatrix Bálint, Olivier Molinier, Henrik Depenbrock, Shivani Nanda, Luis Paz-Ares, Nick Thatcher

Institutions: Institute of Oncology Prof. Dr. Ion Chiricuta, Florida Hospital Cancer Institute, Eli Lilly (United States), Ottumwa Regional Health Center, Poznan University of Medical Sciences, Centre Hospitalier du Mans, Eli Lilly (Germany), Hospital Universitario Virgen del Rocío, The Christie Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2568915723

Cites:

Cited by: 1

Related to: 10